[1]Zhao ZS,Wang YY,Chu YQ,et al.SPARC is associated with gastric cancer progression and poor survival of patients[J].Clin Cancer Res,2010,16:260-268.
[2]Y Sang,F Yan,X Ren.The role and mechanism of CRL4E3 ubiquit in ligase in cancer and its potential therapy implications[J].Oncotarget,2015,6(40):42590-42602.
[3]L Liu,S Lee,J Zhang,et al.CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis[J].Molecular Cell,2009,34:451-460.
[4]J Hannah,PB Zhou.The CUL4A ubiquit in ligase is a potential therapeutic target in skin cancer and other malignancies[J].Chinese J Cancer,2013,32:478-482.
[5]Jackson S,Xiong Y.CRL4S:The CUL4-RING E3 ubiquitin ligases[J].Trends Biochem Sci,2009,34(11):562-570.
[6]U Bedi,VK Mishra,D Wasilewski,et al.Epigenetic plasticity:A central regulator of epithelial-to-mesenchymal transition in cancer[J].Oncotarget,2014,5:2016-2029.
[7]A Puisieux,T Brabletz,J Caramel.Oncogenic roles of EMT-inducing transcription factors[J].Nature Cell Biol,2014,16:488-494.
[8]WL Tam,RA Weinberg.The epigenetics of epithelial-mesenchymal plasticity in cancer[J].Nature Medicine,2013,19:1438-1449.
[9]Song J,Zhang J,Shao J.Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells[J].Int J Immunopathol Pharmacol,2015,28(2):263-269.
[10]Y Wang,M Wen,Y Kwon,et al.CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression[J].Cancer Res,2014,74:520-531.
[11]YL Yang,MS Hung,Y Wang,et al.Lung tumourigenesis in a conditional CUL4A transgenic mouse model[J].J Pathol,2014,233:113-123.
[12]Gheldof A,Berx G.Cadherins and epithelial-to-mesenchymal transition[J].Prog Mol Biol Transl Sci,2013,116:317-336.
[13]Chen D,Wang J,Zhang Y,et al.Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells[J].Int J Gynecol Cancer,2013,23(8):1357-1366.